Disability Benefits for Bladder Cancer

How SSA Evaluates Bladder Cancer Under Listing 13.22

SSA evaluates cancer of the urinary bladder under Blue Book listing 13.22. Whether you meet the listing depends on how deeply the cancer has invaded and whether it has spread or returned. The listing is met when the cancer is:

• Infiltrating beyond the bladder wall — the tumor has grown through the muscle of the bladder into surrounding tissue or nearby organs.
• Recurrent after total cystectomy — the cancer has returned after the entire bladder was surgically removed.
• Inoperable or unresectable — the surgeon could not operate, or could not remove all of the cancer.
• Metastatic — the cancer has spread to or beyond the regional lymph nodes, or to distant sites such as the bones, liver, or lungs.

Superficial and Early-Stage Bladder Cancer

Many bladder cancers are caught early, when they are confined to the inner lining and treated with transurethral resection and bladder instillations such as BCG. Non-invasive bladder cancer usually does not meet listing 13.22 by itself. However, it tends to recur, so people often face repeated cystoscopies, biopsies, and treatments over many years. If you have had your bladder removed, an ileal conduit or urinary diversion brings its own limitations, and radiation and chemotherapy leave lasting fatigue and other effects. SSA must consider all of these when deciding what work you can still do, and it weighs treatment after-effects for a reasonable period after therapy ends.

Medical Evidence SSA Needs for a Bladder Cancer Claim

The evidence that decides most bladder cancer claims documents the depth of invasion and any spread:

• Cystoscopy and biopsy reports establishing the diagnosis and grade.
• Pathology reports from transurethral resection or cystectomy showing how deeply the tumor invaded and whether margins were clear — this is exactly what the listing turns on.
• Imaging — CT urogram, MRI, PET, and bone scans documenting spread beyond the bladder or to lymph nodes and distant sites.
• Operative reports if surgery was attempted or a cystectomy was performed, including any note that the tumor was inoperable or unresectable.
• Treatment and follow-up records — BCG or chemotherapy instillations, systemic chemotherapy, radiation, and the results of surveillance cystoscopies documenting recurrence.

If you have a urinary diversion or ostomy, records describing appliance care, leakage, and infections help show the day-to-day limitations you live with.

Qualifying Without Meeting the Bladder Cancer Listing

If your bladder cancer is superficial or was fully removed, you may still qualify through a residual functional capacity (RFC) assessment. After a cystectomy with a urinary diversion, many people face lifting restrictions to avoid a parastomal hernia, the need for frequent restroom or appliance-care breaks, and a higher risk of infection. Chemotherapy causes fatigue and neuropathy, and repeated procedures under anesthesia mean recovery days that add up.

SSA folds these restrictions into an RFC and compares it to your past work. If you cannot return to your old job, the medical-vocational grid rules apply, weighing your age, education, and skills. Claimants age 50 and older limited to sedentary work, or 55 and older limited to light work, are often found disabled under the grids even without meeting the listing. A documented need for extra unscheduled restroom breaks, or absences of two or more days per month for treatment and recovery, can rule out full-time competitive work by itself.

Tips for a Stronger Bladder Cancer Claim

These steps can make your claim stronger:

• Submit the surgical pathology report early. Depth of invasion and clear-versus-positive margins decide whether the listing is met.
• If your cancer is invasive, recurrent, or metastatic, say so plainly on the application and point to the report that proves it.
• Document urinary diversion problems. Keep a simple log of appliance changes, leakage, and infections and share it with your doctor.
• Report fatigue and neuropathy from chemotherapy at every visit so they are consistently in the record.
• Keep every surveillance appointment, because a steady treatment record makes your claim far more credible.